[Evaluation of clinical practice, medical computerized database and improvement of antibiotic therapy for acute community-acquired pneumonia].

[1]  P. Roger,et al.  Gestion de services, tarification à l’activité, recherche clinique et évaluation des pratiques professionnelles : un même outil informatique , 2008 .

[2]  R. Lee,et al.  A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community‐acquired pneumonia , 2007, Respirology.

[3]  H. Raspe,et al.  Antibiotic treatment of community acquired pneumonia varies widely across Germany. , 2007, The Journal of infection.

[4]  Gina Soriya,et al.  Improved clinical outcomes with utilization of a community-acquired pneumonia guideline , 2007 .

[5]  C. Frei,et al.  Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. , 2006, The American journal of medicine.

[6]  N. Dean,et al.  Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. , 2006, Chest.

[7]  R. Leclercq,et al.  Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  R. Launois,et al.  La tarification à l'activité (T2A) ou la recherche de l'efficience comme impératif déontologique à l'hôpital , 2006 .

[9]  M. Fine,et al.  Does guideline adherence for empiric antibiotic therapy reduce mortality in community-acquired pneumonia? , 2005, American journal of respiratory and critical care medicine.

[10]  R. Stafford,et al.  Fluoroquinolone prescribing in the United States: 1995 to 2002. , 2005, The American journal of medicine.

[11]  J. Bartlett.  International prospective study of klebsiella pneumoniae bacteremia: Implications of extended-spectrum β-lactamase production in nosocomial infections , 2004 .

[12]  R. Menéndez,et al.  Influence of deviation from guidelines on the outcome of community-acquired pneumonia. , 2002, Chest.

[13]  J. Lentino,et al.  Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia. , 2002, International journal of antimicrobial agents.

[14]  J. Fournier,et al.  Bilan médical d’une unité d’hospitalisation ouverte pendant l’épidémie de grippe de l’hiver 1999–2000 , 2001 .

[15]  S. Passos,et al.  Early discharge of infected patients through appropriate antibiotic use. , 2001, Archives of internal medicine.

[16]  J E Stahl,et al.  Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. , 1999, Archives of internal medicine.

[17]  T. Marras,et al.  Use of guidelines in treating community-acquired pneumonia. , 1998, Chest.